Differential gene expression in the nucleus accumbens and frontal cortex of Lewis and Fischer 344 rats relevant to drug addiction

Current Neuropharmacology

Volumn 9, Issue 1, 2011, Pages 143-150

  Higuera Matas, A ^a   Montoya, G L ^a   Coria, S M ^a   Miguens M ^a   Garcia Lecumberri C ^a   Ambrosio, E ^a  

^a UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

Author keywords

Drug addiction; Fischer 344; Gene expression; Genetic differences; Lewis; Microarrays

Indexed keywords

BETA GLOBIN; G PROTEIN COUPLED RECEPTOR; NITRILASE; PROTEIN; PROTEIN LOC300308; PROTEIN LOC363306; PROTEIN LOC688778; PROTEIN LOC689064; PROTEIN LOC692042; PROTEIN MGC72973; PROTEIN RGD1307225; PROTEIN RGD1309362; PROTEIN RGD1559942; PROTEIN RGD1561619; PROTEIN RGD1563482; SODIUM PHOSPHATE COTRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG DEPENDENCE; FATTY ACID METABOLISM; FISCHER 344 RAT; FRONTAL CORTEX; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; LEWIS RAT; LIPOLYSIS; MALE; MICROARRAY ANALYSIS; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; OLIGODENDROGLIA; OXYGEN TRANSPORT; PROTON TRANSPORT; RAT; RNA EXTRACTION; SIGNAL TRANSDUCTION; STRAIN GAUGE TRANSDUCER;

EID: 79953044017     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015911795017290     Document Type: Article

References (52)

1. Goldman, D.; Oroszi, G.; Ducci, F. The genetics of addictions: uncovering the genes. Nat. Rev. Genet., 2005, 6, 521-532.
2. Haile, C.N.; Kosten, T.R.; Kosten, T.A. Genetics of dopamine and its contribution to cocaine addiction. Behav. Genet., 2007, 37, 119-145.
3. Kosten, T.A.; Ambrosio, E. HPA axis function and drug addictive behaviors: insights from studies with Lewis and Fischer 344 inbred rats. Psychoneuroendocrinology, 2002, 27, 35-69.
4. Ambrosio, E.; Goldberg, S.R.; Elmer, G.I. Behavior genetic investigation of the relationship between spontaneous locomotor activity and the acquisition of morphine self-administration behavior. Behav. Pharmacol., 1995, 6, 229-237.
5. George, F.R.; Goldberg, S.R. Genetic approaches to the analysis of addiction processes. Trends Pharmacol. Sci., 1989, 10, 78-83.
6. Kosten, T.A.; Miserendino, M.J.; Haile, C.N.; DeCaprio, J.L.; Jatlow, P.I.; Nestler, E.J. Acquisition and maintenance of intravenous cocaine self-administration in Lewis and Fischer inbred rat strains. Brain Res., 1997, 778, 418-429.
7. Martin, S.; Lyupina, Y.; Crespo, J.A.; Gonzalez, B.; Garcia-Lecumberri, C.; Ambrosio, E. Genetic differences in NMDA and D1 receptor levels, and operant responding for food and morphine in Lewis and Fischer 344 rats. Brain Res., 2003, 973, 205-213.
8. Sanchez-Cardoso, P.; Higuera-Matas, A.; Martin, S.; del Olmo, N.; Miguens, M.; Garcia-Lecumberri, C.; Ambrosio, E. Modulation of the endogenous opioid system after morphine self-administration and during its extinction: a study in Lewis and Fischer 344 rats. Neuropharmacology, 2007, 52, 931-948.
9. Suzuki, T.; Miura, M.; Nishimura, K.; Aosaki, T. Dopaminedependent synaptic plasticity in the striatal cholinergic interneurons. J. Neurosci., 2001, 21, 6492-6501.
10. Beitner-Johnson, D.; Guitart, X.; Nestler, E.J. Dopaminergic brain reward regions of Lewis and Fischer rats display different levels of tyrosine hydroxylase and other morphine- and cocaine-regulated phosphoproteins. Brain Res., 1991, 561, 147-150.
11. Beitner-Johnson, D.; Guitart, X.; Nestler, E.J. Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J. Neurochem., 1993, 61, 1766-1773.
12. Guitart, X.; Beitner-Johnson, D.; Marby, D.W.; Kosten, T.A.; Nestler, E.J. Fischer and Lewis rat strains differ in basal levels of neurofilament proteins and their regulation by chronic morphine in the mesolimbic dopamine system. Synapse, 1992, 12, 242-253.
13. Haile, C.N.; Hiroi, N.; Nestler, E.J.; Kosten, T.A. Differential behavioral responses to cocaine are associated with dynamics of mesolimbic dopamine proteins in Lewis and Fischer 344 rats. Synapse, 2001, 41, 179-190.
14. Ortiz, J.; Fitzgerald, L.W.; Lane, S.; Terwilliger, R.; Nestler, E.J. Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress. Neuropsychopharmacology, 1996, 14, 443-452.
15. Cadoni, C.; Di Chiara, G. Differences in dopamine responsiveness to drugs of abuse in the nucleus accumbens shell and core of Lewis and Fischer 344 rats. J. Neurochem., 2007, 103, 487-499.
16. Dhabhar, F.S.; McEwen, B.S.; Spencer, R.L. Stress response, adrenal steroid receptor levels and corticosteroid-binding globulin levels-a comparison between Sprague-Dawley, Fischer 344 and Lewis rats. Brain Res., 1993, 616, 89-98.
17. Grakalic, I.; Schindler, C.W.; Baumann, M.H.; Rice, K.C.; Riley, A.L. Effects of stress modulation on morphine-induced conditioned place preferences and plasma corticosterone levels in Fischer, Lewis, and Sprague-Dawley rat strains. Psychopharmacology, 2006, 189, 277-286.
18. Koob, G.F.; Volkow, N.D. Neurocircuitry of Addiction. Neuropsychopharmacology, 2010, 35 (1), 217-238.
19. Irizarry, R.A.; Hobbs, B.; Collin, F.; Beazer-Barclay, Y.D.; Antonellis, K.J.; Scherf, U.; Speed, T.P. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 2003, 4, 249-264.
20. Li, H.S.; Zhang, J.Y.; Thompson, B.S.; Deng, X.Y.; Ford, M.E.; Wood, P.G.; Stolz, D.B.; Eagon, P.K.; Whitcomb, D.C. Rat mitochondrial ATP synthase ATP5G3: cloning and upregulation in pancreas after chronic ethanol feeding. Physiol. Genom., 2001, 6, 91-98.
21. Braun, K.P.; Pavlovich, J.G.; Jones, D.R.; Peterson, C.M. Stable acetaldehyde adducts: structural characterization of acetaldehyde adducts of human hemoglobin N terminal beta-globin chain peptides. Alcohol Clin. Exp. Res., 1997, 21, 40-43.
22. Flatscher-Bader, T.; Zuvela, N.; Landis, N.; Wilce, P.A. Smoking and alcoholism target genes associated with plasticity and glutamate transmission in the human ventral tegmental area. Hum. Mol. Genet., 2008, 17, 38-51.
23. Manji, H.; Chen, G.; Potter, W.; Kosten, T.R. Guanine nucleotide binding proteins in opioid-dependent patients. Biol. Psychiatry, 1997, 41, 130-134.
24. Ushijima, I.; Mizuki, Y.; Kobayashi, T.; Aoki, T.; Suetsugi, M.; Usami, K.; Watanabe, Y. Effects of pertussis toxin on behavioral responses during different withdrawal periods from chronic cocaine treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2000, 24, 1369-1377.
25. Iwata, S.; Nomoto, M.; Morioka, H.; Miyata, A. Gene expression profiling in the midbrain of striatal 6-hydroxydopamine-injected mice. Synapse, 2004, 51, 279-286.
26. Gehrke, B.J.; Harrod, S.B.; Cass, W.A.; Bardo, M.T. The effect of neurotoxic doses of methamphetamine on methamphetamine conditioned place preference in rats. Psychopharmacology, 2003, 166, 249-257.
27. Izco, M.; Marchant, I.; Escobedo, I.; Peraile, I.; Delgado, M.; Higuera-Matas, A.; Olias, O.; Ambrosio, E.; O'Shea, E.; Colado, M.I. Mice with decreased cerebral dopamine function following a neurotoxic dose of MDMA exhibit increased ethanol consumption and preference. J. Pharmacol. Exp. Ther., 2007, 322 (3), 1003-1012.
28. Marshall, A.G.; McCarthy, M.M.; Brishnehan, K.M.; Rao, V.; Batia, L.M.; Gupta, M.; Das, S.; Mitra, N.K.; Chaudhuri, J.D. Effect of gestational ethanol exposure on parvalbumin and calretinin expressing hippocampal neurons in a chick model of fetal alcohol syndrome. Alcohol, 2009, 43, 147-161.
29. Todtenkopf, M.S.; Stellar, J.R.; Williams, E.A.; Zahm, D.S. Differential distribution of parvalbumin immunoreactive neurons in the striatum of cocaine sensitized rats. Neuroscience, 2004, 127, 35-42.
30. Hailemariam, T.K.; Huan, C.; Liu, J.; Li, Z.; Roman, C.; Kalbfeisch, M.; Bui, H.H.; Peake, D.A.; Kuo, M.S.; Cao, G.; Wadgaonkar, R.; Jiang, X.C. Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation. Arterioscler. Thromb. Vasc. Biol., 2008, 28, 1519-1526.
31. Russo, S.J.; Mazei-Robison, M.S.; Ables, J.L.; Nestler, E.J. Neurotrophic factors and structural plasticity in addiction. Neuropharmacology, 2009, 56(Suppl 1), 73-82.
32. Russo, S.J.; Wilkinson, M.B.; Mazei-Robison, M.S.; Dietz, D.M.; Maze, I.; Krishnan, V.; Renthal, W.; Graham, A.; Birnbaum, S.G.; Green, T.A.; Robison, B.; Lesselyong, A.; Perrotti, L.I.; Bolanos, C.A.; Kumar, A.; Clark, M.S.; Neumaier, J.F.; Neve, R.L.; Bhakar, A.L.; Barker, P.A.; Nestler, E.J. Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward. J. Neurosci., 2009, 29, 3529-3537.
33. Ohgake, S.; Hashimoto, K.; Shimizu, E.; Koizumi, H.; Okamura, N.; Koike, K.; Matsuzawa, D., Sekine, Y.; Inada, T.; Ozaki, N., Iwata, N.; Harano, M.; Komiyama, T.; Yamada, M.; Sora, I.; Ujike, H.; Shirayama, Y.; Iyo, M. Functional polymorphism of the NQO2 gene is associated with methamphetamine psychosis. Addict. Biol., 2005, 10, 145-148.
34. Brouillette, J.; Quirion, R. Transthyretin: a key gene involved in the maintenance of memory capacities during aging. Neurobiol. Aging, 2008, 29, 1721-1732.
35. Belin, D.; Mar, A.C.; Dalley, J.W.; Robbins, T.W.; Everitt, B.J. High impulsivity predicts the switch to compulsive cocaine-taking. Science, 2008, 320, 1352-1355.
36. Hyman, S.E.; Malenka, R.C.; Nestler, E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci., 2006, 29, 565-598.
37. Schivell, A.E.; Mochida, S.; Kensel-Hammes, P.; Custer, K.L.; Bajjalieh, S.M. SV2A and SV2C contain a unique synaptotagminbinding site. Mol. Cell Neurosci., 2005, 29, 56-64.
38. Daniel, J.M.; Sulzer, J.K.; Hulst, J.L. Estrogen increases the sensitivity of ovariectomized rats to the disruptive effects produced by antagonism of D2 but not D1dopamine receptors during performance of a response learning task. Horm. Behav., 2006, 49, 38-44.
39. Erdos, E.G.; Skidgel, R.A. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J., 1989, 3, 145-151.
40. Marinelli, P.W.; Bai, L.; Quirion, R.; Gianoulakis, C. A microdialysis profile of Met-enkephalin release in the rat nucleus accumbens following alcohol administration. Alcohol Clin. Exp. Res., 2005, 29, 1821-1828.
41. Nieto, M.M.; Wilson, J.; Cupo, A.; Roques, B.P.; Noble, F. Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study. J. Neurosci., 2002, 22, 1034-1041.
42. Hao, S.; Hu, J.; Fink, D.J. Transgene-mediated enkephalin expression attenuates signs of naloxone-precipitated morphine withdrawal in rats with neuropathic pain. Behav. Brain Res., 2009, 197, 84-89.
43. Chen, L.; Hu, L.; Chan, T.H.; Tsao, G.S.; Xie, D.; Huo, K.K., Fu, L.; Ma, S.; Zheng, B.J.; Guan, X.Y. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival. Hepatology, 2009, 50, 122-129.
44. Bourhis, E.; Maheux, J.; Paquet, B.; Kagechika, H.; Shudo, K.; Rompre, P.P.; Rouillard, C.; Levesque, D. The transcription factors Nur77 and retinoid X receptors participate in amphetamine-induced locomotor activities. Psychopharmacology, 2009, 202, 635-648.
45. Lynch, W.J.; Girgenti, M.J., Breslin, F.J.; Newton, S.S.; Taylor, J.R. Gene profiling the response to repeated cocaine selfadministration in dorsal striatum: a focus on circadian genes. Brain Res., 2008, 1213, 166-177.
46. Werme, M.; Thoren, P.; Olson, L.; Brene, S. Running and cocaine both upregulate Dynorphin mRNA in medial caudate putamen. Eur. J. Neurosci., 2000, 12, 2967-2974.
47. del Castillo, C.; Morales, L.; Alguacil, L.F.; Salas, E.; Garrido, E.; Alonso, E.; Perez-Garcia, C. Proteomic analysis of the nucleus accumbens of rats with different vulnerability to cocaine addiction. Neuropharmacology, 2009, 57, 41-48.
48. Bezchlibnyk, Y.B.; Wang, J.F.; Shao, L.; Young, L.T. Insulin-like growth factor binding protein-2 expression is decreased by lithium. Neuroreport, 2006, 17, 897-901.
49. Bezchlibnyk, Y.B.; Xu, L.; Wang, J.F.; Young, L.T. Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment. Brain Res., 2007, 1147, 213-217.
50. Le-Niculescu, H.; Kurian, S.M.; Yehyawi, N.; Dike, C., Patel, S.D.; Edenberg, H.J., Tsuang, M.T.; Salomon, D.R.; Nurnberger, J.I. Jr.; Niculescu, A.B. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol. Psychiatry, 2009, 14, 156-174.
51. Alloy, L.B.; Bender, R.E.; Wagner, C.A.; Whitehouse, W.G.; Abramson, L.Y.; Hogan, M.E.; Sylvia, L.G.; Harmon-Jones, E. Bipolar spectrum-substance use co-occurrence: Behavioral approach system (BAS) sensitivity and impulsiveness as shared personality vulnerabilities. J. Pers. Soc. Psychol., 2009, 97, 549-565.
52. Mody, C.K.; Miller, B.L.; McIntyre, H.B.; Cobb, S.K.; Goldberg, M.A. Neurologic complications of cocaine abuse. Neurology, 1988, 38, 1189-1193.